Загрузка...
Use of parecoxib by continuous subcutaneous infusion for cancer pain in a hospice population
OBJECTIVES: To characterise the use of the parenteral non-steroidal anti-inflammatory drug parecoxib when given by continuous subcutaneous infusion (CSCI) in a hospice population. Clinical experience suggests parecoxib CSCI may be of benefit in this population, but empirical evidence in relation to...
Сохранить в:
| Опубликовано в: : | BMJ Support Palliat Care |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5867430/ https://ncbi.nlm.nih.gov/pubmed/28864447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjspcare-2017-001348 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|